< Back to companies
Frekil

Frekil

Evidence in minutes, not months

San Francisco, California, US

Frekil is an AI-powered platform for pharmaceutical and biotech companies, automating real-world evidence (RWE) generation from EHR and claims data. It also features a Medical Imaging Data Platform that provides AI-assisted annotation, significantly speeding up medical image processing.

Share
Shareable draft
Frekil logo
Get Involved in Frekil

Problem Statement

Pharma companies lose $100M - $1B annually due to inefficient real-world evidence generation.

Core Technology

AI-powered real-world evidence platform; AI-assisted medical imaging annotation.

Key Differentiators

Reduces RWE study timelines from 12-18 months to minutes; Automated statistical analysis plan (SAP) generation aligned with regulatory standards; Propensity score matching, cohort selection, and regression modeling capabilities; Generates publication-ready results including tables, graphs, KM curves, and Forest plots; Generates external control arms for clinical trials; 10x faster annotation cycles for medical imaging compared to traditional approaches; FDA-ready annotation tools with versioning, consensus checks, and audit trails; Full auditability and audit trails for regulatory compliance

Clinical Focus

Medical Imaging; Clinical Research; Radiology; Biostatistics

Company Info

Business Model
B2B SaaS
Founded
2024
Total Funding
Only accessible to MedStartr community members. Join now
Website
www.frekil.com

Categories

Drug Discovery/Development

Disease Areas

Technologies

Real-World EvidenceEHRClaims DataMedical ImagingAutomated Statistical AnalysisAI & Machine Learning

Clinical & IP

🔬

Clinical Validation

FDA-aligned study protocols, OMOP CDM standardization, full audit trails, HIPAA/GDPR compliant architecture with air-gapped design ensuring no clinical data touches AI.

Only accessible to MedStartr community members. Join now

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Sign in to join the conversation.

Sign in to comment
Be the first to comment.

What do you think of Frekil?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in Frekil
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free